Minimally Invasive Salvage Operations for Esophageal Cancer after Definitive Chemoradiotherapy
暂无分享,去创建一个
H. Ishikawa | H. Kuwano | H. Sakurai | H. Kato | M. Nakajima | S. Yamaguchi | K. Sasaki | Hiroto Muroi | M. Kikuchi | Masakazu Takahashi | H. Muroi
[1] M. Yano,et al. Is 18F-FDG-PET useful for predicting R0 resection after induction therapy for initially unresectable locally advanced esophageal carcinoma? , 2017, General Thoracic and Cardiovascular Surgery.
[2] P. Michl,et al. Esophageal Cancer: New Insights into a Heterogenous Disease , 2017, Digestion.
[3] L. Lundell,et al. Systematic review and meta-analysis on the significance of salvage esophagectomy for persistent or recurrent esophageal squamous cell carcinoma after definitive chemoradiotherapy. , 2016, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.
[4] Noboru Motomura,et al. Thoracic and cardiovascular surgery in Japan during 2014 , 2016, General Thoracic and Cardiovascular Surgery.
[5] H. Inoue,et al. Prediction of the invasion depth of superficial squamous cell carcinoma based on microvessel morphology: magnifying endoscopic classification of the Japan Esophageal Society , 2016, Esophagus.
[6] Y. Tachimori,et al. Comprehensive Registry of Esophageal Cancer in Japan, 2009 , 2016, Esophagus.
[7] T. Sano,et al. Salvage Esophagectomy After Definitive Chemoradiotherapy for Patients with Esophageal Squamous Cell Carcinoma: Who Really Benefits from this High-Risk Surgery? , 2015, Annals of Surgical Oncology.
[8] C. Lee,et al. Local Control May be the Key in Improving Treatment Outcomes of Esophageal Squamous Cell Carcinoma Undergoing Concurrent Chemoradiation , 2014, Digestion.
[9] H. Kuwano,et al. Salvage lymphadenectomy for recurrent esophageal cancer after chemoradiotherapy. , 2014, International surgery.
[10] H. Baba,et al. Outcomes of lymphadenectomy for lymph node recurrence after esophagectomy or definitive chemoradiotherapy for squamous cell carcinoma of the esophagus , 2014, General Thoracic and Cardiovascular Surgery.
[11] Y. Tachimori,et al. Prognostic analysis of salvage esophagectomy after definitive chemoradiotherapy for esophageal squamous cell carcinoma: the importance of lymphadenectomy. , 2014, The Journal of thoracic and cardiovascular surgery.
[12] H. Fujita,et al. Salvage lymphadenectomy without esophagectomy is an option for recurrent or residual lymph nodes after definitive chemoradiotherapy for esophageal cancer , 2014, Esophagus.
[13] H. Mashima,et al. Salvage endoscopic submucosal dissection for the esophagus-localized recurrence of esophageal squamous cell cancer after definitive chemoradiotherapy. , 2014, Gastrointestinal endoscopy.
[14] M. Takeuchi,et al. Salvage endoscopic submucosal dissection in patients with local failure after chemoradiotherapy for esophageal squamous cell carcinoma , 2013, Scandinavian journal of gastroenterology.
[15] H. Kato,et al. The efficacy of FDG-PET for the management of esophageal cancer: review article. , 2012, Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia.
[16] A. Darzi,et al. Thoracoscopic esophagectomy in the prone position , 2012, Surgical Endoscopy.
[17] Y. Nishimura,et al. Recent Advances in Diagnosis and Treatment for Malignancies of the Gastrointestinal Tract , 2012, Digestion.
[18] G. Hanna,et al. Transthoracic Versus Transhiatal Esophagectomy for the Treatment of Esophagogastric Cancer: A Meta-Analysis , 2011, Annals of surgery.
[19] E. Oki,et al. Clinical significance of salvage esophagectomy for remnant or recurrent cancer following definitive chemoradiotherapy , 2011, Journal of Gastroenterology.
[20] Quan P. Ly,et al. Esophageal and esophagogastric junction cancers. , 2011, Journal of the National Comprehensive Cancer Network : JNCCN.
[21] M. Kranzfelder,et al. Meta‐analysis of neoadjuvant treatment modalities and definitive non‐surgical therapy for oesophageal squamous cell cancer , 2011, The British journal of surgery.
[22] M. Kitajima,et al. Factors Influencing the Long-Term Survival in Patients with Esophageal Cancer Who Underwent Esophagectomy After Chemoradiotherapy , 2010, World Journal of Surgery.
[23] K. Hayashi,et al. Salvage surgery after definitive chemoradiotherapy for esophageal cancer , 2005, Esophagus.
[24] N. Demartines,et al. Classification of Surgical Complications: A New Proposal With Evaluation in a Cohort of 6336 Patients and Results of a Survey , 2004, Annals of surgery.
[25] H. Kuwano,et al. Value of positron emission tomography in the diagnosis of recurrent oesophageal carcinoma , 2004, The British journal of surgery.
[26] K. Yasuda,et al. Thoracic and Cardiovascular Surgery in Japan during 2000 : Annual Report by The Japanese Association for Thoracic Surgery , 2002 .
[27] R. Ginsberg,et al. INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[28] R. Postlethwait. Esophagectomy without thoracotomy. , 1979, The Annals of thoracic surgery.
[29] Jianfang Liu,et al. Improving CT detection sensitivity for nodal metastases in oesophageal cancer with combination of smaller size and lymph node axial ratio , 2017, European Radiology.
[30] MSc MA Sheraz R. Markar MRCS,et al. Assessment of Short-Term Clinical Outcomes following Salvage Esophagectomy for the Treatment of Esophageal Malignancy: Systematic Review and Pooled Analysis , 2013, Annals of Surgical Oncology.
[31] Leslie H. Sobin,et al. TNM Classification of Malignant Tumours, 7th Edition , 2009 .